Abmining

Massive antibody mining, an unique platform for accelerating R&D timeline of therapeutic antibodies.

Proprietary Topo-Antibody® with global epitope coverage combines with digital immortalization facilitate accelerated timeline for the development of new antibody therapeutics.

If you are interested in Abmining project, please feel free to contact us for further discussion!

  • PRIM

    Recombinant protein as a Pan Fc Receptor Interacting molecule.

    Learn More 
  • PD-L1 Decoy

    Cancer treatment via symbiosis with tumor tissues through slowing down the progression of cancer-triggered cachexia.

    Learn More 
  • Abmining

    Massive antibody mining, an unique platform for accelerating R&D timelines of therapeutic antibodies.

    Learn More 
  • SSB-4

    A Non-Antibody Biologics engineered for Blocking of SARS-CoV-2 Binding to ACE2.

    Learn More